Viewing Study NCT06918912


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-31 @ 8:22 AM
Study NCT ID: NCT06918912
Status: RECRUITING
Last Update Posted: 2025-04-09
First Post: 2025-03-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure
Sponsor: Istituto Clinico Humanitas
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module